TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Biofutures International Plc | ||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||||||
An acquisition or disposal of voting rights | Yes | ||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | No | ||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | No | ||||||||
An event changing the breakdown of voting rights | No | ||||||||
Other (please specify): | No | ||||||||
3. Full name of person(s) subject to the notification obligation:
|
Gartmore Investment Limited | ||||||||
4. Full name of shareholder(s) (if different from 3.):
| See attached Schedule | ||||||||
5. Date of the transaction and date on which the threshold is crossed or reached:
|
5th July 2010 | ||||||||
6. Date on which issuer notified:
|
6th July 2010 | ||||||||
7. Threshold(s) that is/are crossed or reached:
|
11% | ||||||||
8. Notified details: | |||||||||
A: Voting rights attached to shares
| |||||||||
Class/type of
| Situation previous | Resulting situation after the triggering transaction | |||||||
Number | Number | Number | Number of voting | % of voting rights | |||||
Direct | Direct | Indirect | Direct | Indirect | |||||
ORDINARY GB00B12B4T47
| 15,934,030 | 15,934,030 | 16,934,030 | - | 16,934,030 | - | 11.210% | ||
B: Qualifying Financial Instruments | |||||||||
Resulting situation after the triggering transaction
| |||||||||
Type of financial | Expiration | Exercise/ | Number of voting
| % of voting | |||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | |||||||||
Resulting situation after the triggering transaction
| |||||||||
Type of financial | Exercise | Expiration | Exercise/ | Number of voting | % of voting rights
| ||||
Total (A+B+C)
| |||||||||
Number of voting rights | Percentage of voting rights | ||||||||
16,934,030 | 11.210% | ||||||||
9. Chain of controlled undertakings through which the voting rights and/or the | |||||||||
| |||||||||
Proxy Voting:
| |||||||||
10. Name of the proxy holder:
| |||||||||
11. Number of voting rights proxy holder will cease to hold:
| |||||||||
12. Date on which proxy holder will cease to hold voting rights:
| |||||||||
13. Additional information:
| All figures are based on the Company's issued share capital of 151,060,000 as provided by Exshare
E-mail contact: RDU@Gartmore.com
| ||||||||
14. Contact name:
| RDU | ||||||||
15. Contact telephone number:
| 0207 782 2324 | ||||||||
For further information contact: |
JOE WONG, CHIEF EXECUTIVE OFFICER, BIOFUTURES INTERNATIONAL PLC - +6012 31 0626
DEREK CROWHURST, RELIGARE CAPITAL MARKETS (NOMAD) - 0207 444 0800
DANIEL BRIGGS, RELIGARE CAPITAL MARKETS (BROKER) - 0207 444 0500 |
Schedule
Fund Managing Company | UK Registered Owner | Beneficial Owner | % of Issued Share Capital | Shares Held |
Gartmore Fund Managers Limited | HSBC Global Custody Nominee UK Ltd | Gartmore Fund Managers Ltd A/C Gartmore UK & Irish Smaller Companies | 4,375,000 | 2.896% |
Gartmore Investment Limited | Nortrust Nominees Limited | Strathclyde Pension Fund | 5,550,000 | 3.674% |
Gartmore Growth Opportunities | Gartmore Growth Opportunities Plc | 1,034,030 | 0.685% | |
Vidacos Nominees Ltd A/C 2303 | The Alphagen Volantis Fund Limited | 5,975,000 | 3.955% | |
Total | 16,934,030 | 11.210% | ||
RNS news service provided by Hemscott Group Limited.